Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 5% – Tale of the Tape

None of the estimates for this industry stock were revised over the past seven days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Genocea Biosciences currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

A better-ranked stock in the same industry is Auris Medical Holding AG (EARS), sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>